Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,176,857
-$38,170 QoQ
Shares Held
9,315
+6.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,000
of 2,266 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hodges Capital Management Inc. holds $30,757,198 across 7 Drug Manufacturers - General names. GILD ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,780 | $12,929,856 | |
| 2 | JNJ |
Johnson & Johnson
|
23,026 | $5,847,913 | |
| 3 | ABBV |
AbbVie Inc.
|
19,642 | $4,942,712 | |
| 4 | AMGN |
Amgen Inc
|
7,363 | $2,666,289 | |
| 5 | NVO |
Novo Nordisk A S
|
51,300 | $2,459,322 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
9,315 | $1,176,857 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,714 | $734,249 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,176,857 | 9,315 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,215,027 | 8,718 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,052,127 | 8,572 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $958,485 | 8,635 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $190,485 | 1,700 | Shares | Sole | 2025-06-02 | |
| No filing history on record for this holder in this stock. | ||||||